Evosep
DenmarkEntry
2025
Hold
1yr
Status
Active
Who owns Evosep?
Evosep is a Danish MedTech company, currently owned by Nordic Capital since 2025. It changed hands in 2025, when Eifo sold.
Hand-verified · updated 2026-08-18
Open JSON · CC-BY
Most recent investor
Nordic CapitalNordic Capital Fund XI · 2023 · Buyout
2 ownership periods · full history below
Key facts
HQDenmark
SectorMedTech
StatusActive
Ownership history
2 ownership periods
Active
EifoExited 2025
2016 · 2025(9yr) · EIFO (direct equity) · 1992 · VC
Eifo sold Evosep to Nordic Capital in 2025 after 9 years.
Nordic CapitalActive
2025 · present(1yr) · Nordic Capital Fund XI · 2023 · Buyout
More from Nordic Capital Fund XI
Other portfolio companies in the same fund.
UK
Sweden
NorwayMore PE-backed in MedTech
Comparable medtech deals from other GPs.
US
GermanyQuestions
Who owns Evosep?
Evosep is currently owned by Nordic Capital, through Nordic Capital Fund XI, since 2025.
When did Nordic Capital acquire Evosep?
Nordic Capital acquired Evosep in 2025.
Who did Evosep sell to?
Eifo sold Evosep to Nordic Capital in 2025 (Secondary).
Who has owned Evosep over time?
Evosep has been through 2 private-equity ownership periods: Eifo · via EIFO (direct equity) · 2016–2025 · sold to Nordic Capital · (Secondary); Nordic Capital · via Nordic Capital Fund XI · since 2025.
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue